Research and Markets: Hemoglobin A1c Testing Devices Market Report 2013-2019: Overview, End-Use, Technology and Geographic Analysis

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/tvt54s/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.

The global hemoglobin A1c testing devices market is characterized by the presence of some of the major companies including Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc. These players are seeking to develop HbA1c analyzers with quicker turnaround time, higher accuracy and reliable results. Moreover, approval of devices for diagnosis of diabetes has reinforced the development activities of these organizations to introduce products for rapid and early diagnosis.

Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013 and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With these diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes.

Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster pace during the forecast period.

Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview

Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use

Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology

Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography

Chapter 7 Recommendations

Chapter 8 Company Profiles

  • Abbott Laboratories
  • Alere, Inc.
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Chek Diagnostics (Polymer Technology Systems, Inc.)
  • Danaher Corporation (Beckman Coulter)
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • Sebia
  • Siemens Healthcare
  • Tosoh Corporation
  • Trinity Biotech plc

For more information visit http://www.researchandmarkets.com/research/tvt54s/hemoglobin_a1c

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices